Author:
Shillah Wilfred B.,Yahaya James J.,Morgan Emmanuel D.,Bintabara Deogratius
Abstract
AbstractMicrovascular complications encompass a group of diseases which result from long-standing chronic effect of diabetes mellitus (DM). We aimed to determine the prevalence of microvascular complications and associated risk factors among patients with type 2 diabetes mellitus (T2DM). A cross-sectional analytical hospital-based study was conducted at Singida and Dodoma regional referral hospitals in Tanzania from December 2021 to September 2022. A total of 422 patients with T2DM were included in the analysis by determining the prevalence of microvascular complications and their predictors using multivariable logistic regression analysis. A two-tailed p value less than 0.05 was considered statistically significant. The prevalence of microvascular complications was 57.6% (n = 243) and diabetic retinopathy was the most common microvascular complication which accounted for 21.1% (n = 89). Having irregular physical activity (AOR = 7.27, 95% CI = 2.98–17.71, p < 0.001), never having physical activity (AOR = 2.38, 95% CI = 1.4–4.01, p = 0.013), being hypertensive (AOR = 5.0, 95% CI = 2.14–11.68, p = 0.030), having T2DM for more than 5 years (AOR = 2.74, 95% CI = 1.42–5.26, p = 0.025), being obese (AOR = 2.63, 95% CI = 1.22–5.68, p = 0.010), and taking anti-diabetic drugs irregularly (AOR = 1.94, 95% CI = 0.15–0.77, p < 0.001) were the predictors of microvascular complications. This study has revealed a significant proportion of microvascular complications in a cohort of patients with T2DM. Lack of regular physical activity, being obese, taking anti-diabetic drugs irregularly, presence of hypertension, and long-standing duration of the disease, were significantly associated with microvascular complications.
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Banday, M. Z., Sameer, A. S. & Nissar, S. Pathophysiology of diabetes: An overview. Avicenna J. Med. 10, 174–188 (2020).
2. Sun, H. et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diab. Res. Clin. Pract. https://doi.org/10.1016/j.diabres.2021.109119 (2022).
3. Goedecke, J. H. & Mendham, A. E. Pathophysiology of type 2 diabetes in sub-Saharan Africans. Diabetologia 65, 1967–1980 (2022).
4. Malindisa, E. K., Balandya, E., Mashili, F., Iddi, S. & Njelekela, M. The magnitude of type 2 diabetes mellitus and cardiovascular disease risk factors among young adults in urban settings: A cross-sectional survey in Mwanza, Tanzania. Pan Afr. Med. J. 42, 19 (2022).
5. Kidanie, B. B. et al. Determinants of diabetic complication among adult diabetic patients in debre markos referral hospital, northwest Ethiopia, 2018: Unmatched case control study. Diab. Metab. Syndr. Obes. 13, 237–245 (2020).